Home » Pacerone » Pacerone Lawsuit

Pacerone Lawsuit

• More on Pacerone
  • Pacerone Lawsuit

Pacerone lawsuits are being investigated on behalf of patients who suffered serious complications, including pulmonary toxicity and pulmonary fibrosis, allegedly related to the use of this heart medication. Families who have lost a loved one to these side effects may also be eligible to file a claim.

Pacerone Legal Reviews Now Available

Bernstein Liebhard LLP is now offering free, no-obligation legal reviews to patients who may have been harmed by Pacerone, or their surviving loved ones. To learn more, please contact our legal team by calling (888) 994-5118.

Pacerone: What’s the Problem?

Pacerone (amiodarone) is an antiarrhythmic agent marketed by Upsher-Smith Laboratories. It is intended as “a drug of last resort for patients suffering from documented recurrent life-threatening ventricular fibrillation and ventricular tachycardia.”  However, plaintiffs in amiodarone lawsuits claim that medications containing this active ingredient are frequently prescribed as an off-label treatment for atrial fibrillation.  They further contend that the drugs’ manufacturers aggressively and illegally promoted amiodarone products for these unapproved uses.

Serious complications allegedly related to the use of Pacerone include:

• Pulmonary fibrosis
• Pulmonary toxicity
• Liver injury
• Vision problems/blindness
• Worsening arrhythmia
• Death

FDA Amiodarone Warnings

The U.S. Food & Drug Administration has issued a number of warnings for amiodarone products:

• May 2005: The FDA warned that amiodarone may cause liver toxicity, hepatic (liver) injury, and worsened arrhythmia.
• December 2011: The FDA advised that Zocor (simvastatin) dosage should not exceed 20 mg when the statin medication is being used in combination with amiodarone. The dosage recommendations were intended to reduce the risk of serious muscle injury (myopathy), including rhabdomyolysis, a condition which can lead to kidney damage, kidney failure and death.
• March 2015: The FDA recommended that the hepatitis C medications Harvoni and Sovaldi not be co-administered with amiodarone. The recommendation was based reports of nine severe cases of symptomatic bradycardia (slow heart rate) and one fatal cardiac arrest in individuals caused by amiodarone and Harvoni or amiodarone and Sovaldi plus another direct-acting antiviral.

Amiodarone Litigation

In March 2015, the daughter of  former University of Alabama athletic director Mal Moore filed a wrongful death lawsuit against two amiodarone manufacturers, alleging that the “very dangerous” drug caused his death two years earlier.  Mr. Moore had taken the medication for 90 days in 2008 to treat an irregular heartbeat. He was diagnosed with pulmonary fibrosis five years later. Amiodarone products are not approved to treat atrial fibrillation. But the lawsuit claims that the defendants systematically ignored risks associated with the drug and aggressively marketed it as a first-line treatment choice for patients like Mr. Moore.  Read More

Injured by Pacerone? Contact an Attorney Today.

Individuals who suffered serious complications allegedly related to Pacerone may be entitled to compensation for medical bills, lost wages, pain and suffering and more. To discuss filing a Pacerone lawsuit with our legal team, please contact Bernstein Liebhard today at (888) 994-5118.